Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Minerva Neurosciences, Inc. (NERV)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
2.2100+0.0700 (+3.27%)
At close: 04:00PM EST
2.3000 +0.09 (+4.07%)
After hours: 06:21PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close2.1400
Open2.1500
Bid2.2000 x 1100
Ask2.3000 x 800
Day's Range2.1500 - 2.3400
52 Week Range1.2600 - 15.2700
Volume51,593
Avg. Volume168,588
Market Cap11.802M
Beta (5Y Monthly)-0.07
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NERV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Minerva Neurosciences, Inc
    Analyst Report: Johnson & JohnsonJohnson & Johnson is a diversified healthcare company that develops, manufactures and markets products in three primary lines of business: Pharmaceuticals, Medical Devices and Diagnostics, and Consumer Products.
    Rating
    Fair Value
    Economic Moat
    8 hours agoArgus Research
View more
Advertisement
Advertisement